CP-424,391
Phase 2Terminated 0 watching 0 views this week⚡ Active
51
Development Stage
✓
Pre-clinical✓
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Aging
Conditions
Aging, Frail Older Adults
Trial Timeline
Dec 1, 1999 → Oct 1, 2001
NCT ID
NCT00527046About CP-424,391
CP-424,391 is a phase 2 stage product being developed by Pfizer for Aging. The current trial status is terminated. This product is registered under clinical trial identifier NCT00527046. Target conditions include Aging, Frail Older Adults.
Hype Score Breakdown
Clinical
17
Activity
12
Company
9
Novelty
5
Community
5
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00527046 | Phase 2 | Terminated |
Competing Products
20 competing products in Aging